コンパニオン診断薬の世界市場は、2021年に約68億米ドルと評価され、予測期間の2022年から2029年には11.0%以上の健全な成長率で成長すると予測されています。コンパニオン診断は、同等の生物学的製品または医薬品の使用が安全で効果的であることを確認するために使用される検査です。これらの検査は通常、がんの診断に使用されます。この際、特定されたバイオマーカーに基づいて適切な薬が推奨されます。特定の患者の反応に基づいて、これらの検査は個別の治療を提供します。コンパニオン診断市場は、がんの発生率の増加やさまざまな適応症に対する新しい検査の規制当局の承認の増加などの要因により拡大しています。
世界的ながんの有病率の上昇が市場の成長を促進しており、2022年2月に世界保健機関（WHO）が発表した統計によると、世界では毎年約40万人の子どもががんを発症しています。また、世界がん研究基金インターナショナル（World Cancer Research Fund International）が発表した統計によると、2020年には、世界で18,094,716万人のがん患者が診断されたとのことです。国際がん研究機関（The International Agency for Research on Cancer）の推計によると、2040年までに新たに発生するがん患者数は2,750万人にのぼるとされており、世界的ながんの負担増が懸念されています。世界的ながん罹患率の上昇に伴い、これらの検査の利用が増加しており、市場の拡大を後押ししています。また、様々な適応症でこれらの検査が承認されることで、市場の拡大が期待されます。たとえば、2022 年 8 月に米国 FDA は、Thermo Fisher Scientific Inc.社のOncomine Dx Target Testをコンパニオン診断（CDx）として承認しました。この検査では、HER2 （ERBB2）活性化変異（SNVおよびExon 20挿入）を示す非小細胞肺がん腫瘍を特定します。さらに、医薬品および診断技術の共同開発と政府の好意的な支援により、市場は有利な成長を生み出しています。ただし、医薬品開発と関連する臨床試験のコストが高いため、市場の成長が止まる可能性があります。
コンパニオン診断の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、創薬活動の活発化、有病率の上昇、規制当局の承認取得の増加により、売上高で市場を支配しています。一方、アジア太平洋地域は、疾病の増加、医薬品開発のための共同研究の増加、主要企業の地域的拡大、政府および非営利団体の市場参入などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Companion Diagnostics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Companion Diagnostics Market, by Technology, 2019-2029 (USD Billion)
1.2.3. Companion Diagnostics Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Companion Diagnostics Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Companion Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Companion Diagnostics Market Dynamics
3.1. Companion Diagnostics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of Cancer
3.1.1.2. Rising Regulatory Approvals of New Tests for Different Indications
3.1.2. Market Challenges
3.1.2.1. High Cost of Drug Development and Associated Clinical Trials
3.1.3. Market Opportunities
3.1.3.1. Co-development of Drug and Diagnostic Technology
3.1.3.2. Favourable government support
Chapter 4. Global Companion Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Companion Diagnostics Market, by Technology
6.1. Market Snapshot
6.2. Global Companion Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Companion Diagnostics Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
6.4. Companion Diagnostics Market, Sub Segment Analysis
6.4.1. Immunohistochemistry (IHC)
6.4.2. Polymerase Chain Reaction (PCR)
6.4.3. In-situ Hybridization (ISH)
6.4.4. Real-time PCR (RT-PCR)
6.4.5. Gene Sequencing
6.4.6. Other Technologies
Chapter 7. Global Companion Diagnostics Market, by Indication
7.1. Market Snapshot
7.2. Global Companion Diagnostics Market by Indication, Performance - Potential Analysis
7.3. Global Companion Diagnostics Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Companion Diagnostics Market, Sub Segment Analysis
7.4.1. Lung Cancer
7.4.2. Breast Cancer
7.4.3. Colorectal Cancer
7.4.4. Leukemia
7.4.5. Melanoma
7.4.6. Other Indications
Chapter 8. Global Companion Diagnostics Market, by End User
8.1. Market Snapshot
8.2. Global Companion Diagnostics Market by End User, Performance - Potential Analysis
8.3. Global Companion Diagnostics Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Companion Diagnostics Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biopharmaceutical Companies
8.4.2. Reference Laboratories
8.4.3. CROs
8.4.4. Others
Chapter 9. Global Companion Diagnostics Market, Regional Analysis
9.1. Companion Diagnostics Market, Regional Market Snapshot
9.2. North America Companion Diagnostics Market
9.2.1. U.S. Companion Diagnostics Market
9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Companion Diagnostics Market
9.3. Europe Companion Diagnostics Market Snapshot
9.3.1. U.K. Companion Diagnostics Market
9.3.2. Germany Companion Diagnostics Market
9.3.3. France Companion Diagnostics Market
9.3.4. Spain Companion Diagnostics Market
9.3.5. Italy Companion Diagnostics Market
9.3.6. Rest of Europe Companion Diagnostics Market
9.4. Asia-Pacific Companion Diagnostics Market Snapshot
9.4.1. China Companion Diagnostics Market
9.4.2. India Companion Diagnostics Market
9.4.3. Japan Companion Diagnostics Market
9.4.4. Australia Companion Diagnostics Market
9.4.5. South Korea Companion Diagnostics Market
9.4.6. Rest of Asia Pacific Companion Diagnostics Market
9.5. Latin America Companion Diagnostics Market Snapshot
9.5.1. Brazil Companion Diagnostics Market
9.5.2. Mexico Companion Diagnostics Market
9.5.3. Rest of Latin America Companion Diagnostics Market
9.6. Rest of The World Companion Diagnostics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Agilent Technologies Inc.
10.2.3. F.Hoffmann-La Roche Ltd
10.2.4. Biomerieux SA
10.2.5. Qiagen NV
10.2.6. Siemens Healthcare Gmbh
10.2.7. Thermo Fisher Scientific Inc.
10.2.8. Danaher Corporation (Beckman Coulter Inc.)
10.2.9. Almac Group
10.2.10. Illumina Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Companion Diagnostics Market, report scope
TABLE 2. Global Companion Diagnostics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Companion Diagnostics Market estimates & forecasts by Technology 2019-2029 (USD Billion)
TABLE 4. Global Companion Diagnostics Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 5. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Companion Diagnostics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Companion Diagnostics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Companion Diagnostics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Companion Diagnostics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Companion Diagnostics Market
TABLE 70. List of primary sources, used in the study of global Companion Diagnostics Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Companion Diagnostics Market, research methodology
FIG 2. Global Companion Diagnostics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Companion Diagnostics Market, key trends 2021
FIG 5. Global Companion Diagnostics Market, growth prospects 2022-2029
FIG 6. Global Companion Diagnostics Market, porters 5 force model
FIG 7. Global Companion Diagnostics Market, pest analysis
FIG 8. Global Companion Diagnostics Market, value chain analysis
FIG 9. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Companion Diagnostics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Companion Diagnostics Market, regional snapshot 2019 & 2029
FIG 15. North America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Companion Diagnostics Market 2019 & 2029 (USD Billion)
FIG 19. Global Companion Diagnostics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
